Clinical trials recruiting for Atherosclerosis Cardiovascular Disease
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Orforglipron | 1 |
| Red Wine | 1 |
| Tirzepatide | 1 |
| White Wine | 1 |
Self-screener
Recruiting trials
- A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes)
- Deciphering the Effect of Moderate Wine Consumption on Healthy Aging Through Postprandial Extracellular Vesicles.
- Evaluating Atherosclerotic Disease Progression in Patients With Diabetes Mellitus
- Isometric Resistance Exercise on Accelerated Atherosclerosis in Hypertension
- The Effects of Tirzepatide in People With Overweight/Obesity and Coronary Artery Disease
Related conditions
Trials recruiting for Atherosclerosis Cardiovascular Disease often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Atherosclerosis Cardiovascular Disease trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.